UnknownNot Applicable

Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis

South Korea56 participantsStarted 2023-07-21

Plain-language summary

The primary purpose of this study is to compare the therapeutic efficacy of intrauterine device and uterine artery embolization for uterine adenomyosis.

Who can participate

Age range19 Years – 48 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1\. Women with symptomatic fibroids (age: 19 - 48 years old) 2. Hemglobin \< 12g/dL, 3. Symptoms of adenomysis (Menorrhagia, Dysmenorrhea) Exclusion Criteria: 1\. Gynecologic malignancy 2. Ongoing infection or inflammation 3. Coagulopathy (platelet \< 50,000 or INR \> 1.5) 4. Concomitant endometriosis 5. Pregnancy

What they're measuring

Hemoglobin level

Timeframe: Hemoglobin level at 6 and 12 months after each procedure

Trial details

NCT IDNCT06043583

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04

Contact for this trial

Man-Deuk Kim

82-10-8625-2197 mdkim@yuhs.ac

View on ClinicalTrials.gov More Adenomyosis trials